Safety and efficacy of zoledronic acid for prevention of bone loss after gastric bypass: pilot study

被引：0
|
作者：
Liu, Yi [1 ]
Cheney, Michael [2 ]
Cote, Maya [2 ]
Lindeman, Katherine [2 ]
Rushin, Claire [2 ]
Yu, Elaine [2 ]
机构：
[1] Lahey Hosp & Med Ctr, Burlington, MA USA
[2] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-667
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] Zoledronic Acid Versus Alendronate for the Prevention of Bone Loss after Heart or Liver Transplantation
    Shane, Elizabeth
    Cohen, Adi
    Stein, Emily M.
    McMahon, Donald J.
    Zhang, Chiyuan
    Young, Polly
    Pandit, Kavita
    Staron, Ronald B.
    Verna, Elizabeth C.
    Brown, Robert
    Restaino, Susan
    Mancini, Donna
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4481 - 4490
  • [2] Pilot study on prophylactic use of zoledronic acid to prevent bone loss in allogeneic recipients
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Moon, J. H.
    Kim, S. N.
    Lee, S. J.
    Suh, J. S.
    Lee, K. S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S180 - S180
  • [3] Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial
    Gam, Soren
    Gram, Bibi
    Juhl, Claus Bogh
    Hermann, Anne Pernille
    Hansen, Stinus Gadegaard
    TRIALS, 2022, 23 (01)
  • [4] Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial
    Søren Gam
    Bibi Gram
    Claus Bogh Juhl
    Anne Pernille Hermann
    Stinus Gadegaard Hansen
    Trials, 23
  • [5] Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients
    Chae, Y. S.
    Kim, J. G.
    Moon, J. H.
    Kim, S. N.
    Lee, S. J.
    Kim, Y. J.
    Sohn, S. K.
    BONE MARROW TRANSPLANTATION, 2009, 44 (01) : 35 - 41
  • [6] Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients
    Y S Chae
    J G Kim
    J H Moon
    S N Kim
    S J Lee
    Y J Kim
    S K Sohn
    Bone Marrow Transplantation, 2009, 44 : 35 - 41
  • [7] Prevention of bone loss and fracture after lung transplantation - A pilot study
    Cahill, BC
    O'Rourke, MK
    Parker, S
    Stringham, JC
    Karwande, SV
    Knecht, TP
    TRANSPLANTATION, 2001, 72 (07) : 1251 - 1255
  • [8] EFFICACY AND SAFETY OF ZOLEDRONIC ACID 5 MG IN THE PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH OSTEOPENIA: THE HORIZON PREVENTION STUDY
    McClung, Michael R.
    Miller, Paul
    Recknor, Christopher
    Ruzucky, Maryellen
    BucciRechtweg, Christina
    Yu, Sue
    Benhamou, Claude Laurent
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S212 - S213
  • [9] Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study
    Nirmeen A. Sabry
    Emad E. Habib
    Medical Oncology, 2011, 28 : 584 - 590
  • [10] Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study
    Sabry, Nirmeen A.
    Habib, Emad E.
    MEDICAL ONCOLOGY, 2011, 28 (02) : 584 - 590
12345